In the type 2 diabetes group, the sample size was 710 patients
In this context, certain formulations have been developed to align with these biological mechanisms particularly those centered around Akkermansia muciniphila , butyrate-producing bacteria, and microbiome-supportive compounds
Sleep Duration, Sleep Quality and the Risk of Being Obese: Evidence from the Australian Panel Survey. Sleep Medicine , vol
This brief discusses the current landscape of Medicaid GLP-1 coverage and examines recent trends in Medicaid prescriptions and gross spending on GLP-1s
These drugs are particularly valuable for patients with obesity-related conditions like metabolic syndrome, prediabetes, or as recently approved, obstructive sleep apnea (OSA) the FDA approved tirzepatide in OSA because weight loss led to significant improvement in apnea-hypopnea index and symptom resolutionfda.govfda.gov